1309598-68-2 Usage
Uses
Used in Pharmaceutical Synthesis:
(S)-1-(2,6-Difluorophenyl)ethanamine hydrochloride is used as a key intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs with specific therapeutic properties. Its unique structure allows for the creation of molecules with potential medicinal applications.
Used in Agrochemical Synthesis:
In the agrochemical industry, (S)-1-(2,6-Difluorophenyl)ethanamine hydrochloride is utilized as a precursor in the production of various agrochemicals, such as pesticides and herbicides, due to its potential to enhance the effectiveness of these products.
Used in Organic Synthesis:
(S)-1-(2,6-Difluorophenyl)ethanamine hydrochloride serves as a versatile building block in organic synthesis, allowing for the creation of a wide array of organic compounds for research and commercial purposes.
Used in Chemical Research:
(S)-1-(2,6-Difluorophenyl)ethanamine hydrochloride is also used in chemical research as a model or reagent to study various chemical reactions and mechanisms, contributing to the advancement of knowledge in the field of chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 1309598-68-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,0,9,5,9 and 8 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1309598-68:
(9*1)+(8*3)+(7*0)+(6*9)+(5*5)+(4*9)+(3*8)+(2*6)+(1*8)=192
192 % 10 = 2
So 1309598-68-2 is a valid CAS Registry Number.
1309598-68-2Relevant academic research and scientific papers
BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS
-
Paragraph 1208-1209; 1222-1223, (2018/06/29)
This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy and/or epileptic seizure disorders.
PYRIMIDINEDIONE COMPOUNDS AGAINST CARDIAC CONDITIONS
-
Paragraph 0082-0083; 0154-0155, (2015/01/07)
Provided are novel pyrimidine dione compounds and pharmaceutically acceptable salts thereof, that are useful for the treatment of hypertrophic cardiomyopathy (HCM) and conditions associated with left ventricular hypertrophy or diastolic dysfunction. The synthesis and characterization of the compounds and pharmaceutically acceptable salts thereof, are described, as well as methods for treating HCM and other forms of heart disease.
